South Korea Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The South Korean generics market had total revenues of $5.2 billion in 2022, representing a compound annual growth rate (CAGR) of 4.4% between 2017 and 2022.
- 麻豆原创 consumption volume increased with a CAGR of 5% between 2017 and 2022, to reach a total of 53.5% in 2022.
- In 2022, the approval of generic medications鈥攁 significant source of income for Korean pharmaceutical firms reached听804.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts
Reasons to Buy
- What was the size of the South Korea generics market by value in 2022?
- What will be the size of the South Korea generics market in 2027?
- What factors are affecting the strength of competition in the South Korea generics market?
- How has the market performed over the last five years?
- What are the main segments that make up South Korea's generics market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. 麻豆原创 rivalry
1.7. Competitive landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
3.2. 麻豆原创 volume
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
5.2. 麻豆原创 volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Yuhan Corp
8.4. Viatris Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: South Korea generics market value: $ million, 2017-22
Table 2: South Korea generics market volume: %, 2017-22
Table 3: South Korea generics market geography segmentation: $ million, 2022
Table 4: South Korea generics market value forecast: $ million, 2022-27
Table 5: South Korea generics market volume forecast: %, 2022-27
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Yuhan Corp: key facts
Table 14: Yuhan Corp: Annual Financial Ratios
Table 15: Yuhan Corp: Key Employees
Table 16: Yuhan Corp: Key Employees Continued
Table 17: Viatris Inc.: key facts
Table 18: Viatris Inc.: Annual Financial Ratios
Table 19: Viatris Inc.: Key Employees
Table 20: Viatris Inc.: Key Employees Continued
Table 21: South Korea size of population (million), 2018-22
Table 22: South Korea gdp (constant 2005 prices, $ billion), 2018-22
Table 23: South Korea gdp (current prices, $ billion), 2018-22
Table 24: South Korea inflation, 2018-22
Table 25: South Korea consumer price index (absolute), 2018-22
Table 26: South Korea exchange rate, 2018-22
List of Figures
List of Figures
Figure 1: South Korea generics market value: $ million, 2017-22
Figure 2: South Korea generics market volume: %, 2017-22
Figure 3: South Korea generics market geography segmentation: % share, by value, 2022
Figure 4: South Korea generics market value forecast: $ million, 2022-27
Figure 5: South Korea generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in South Korea, 2022
Figure 7: Drivers of buyer power in the generics market in South Korea, 2022
Figure 8: Drivers of supplier power in the generics market in South Korea, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2022
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2022
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Yuhan Corp
Viatris Inc.
听
听
*If Applicable.
